Literature DB >> 3080876

Effect of prostaglandins on renal salt and water excretion.

K H Raymond, M D Lifschitz.   

Abstract

There are several important mechanisms by which renal prostaglandins modulate renal salt and water excretion. The role of endogenous renal prostaglandins in facilitating urinary sodium excretion and the individual nephron segments that are affected by renal prostaglandins are reviewed. The role of the administration of nonsteroidal anti-inflammatory agents on the kidney's ability to excrete salt and water both physiologically and clinically is summarized. The potential role for endogenous prostaglandins to antagonize the effect of antidiuretic hormone and to alter renal water excretion is also described. The clinical consequences of taking nonsteroidal anti-inflammatory drugs in terms of hyperkalemia, sodium retention with associated edema, and possible hyponatremia are all discussed. Although these clinical consequences are quite uncommon statistically, there are certain subsets of patients for whom additional concern is important.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080876     DOI: 10.1016/0002-9343(86)90929-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension.

Authors:  Nayaab S Khan; Chi Young Song; Shyamala Thirunavukkarasu; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Am J Hypertens       Date:  2015-06-04       Impact factor: 2.689

2.  Liver cirrhosis induces renal and liver phospholipase A2 activity in rats.

Authors:  B S Vishwanath; F J Frey; G Escher; J Reichen; B M Frey
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

3.  Urinary excretion of 6-keto prostaglandin F1 alpha in pre-eclampsia.

Authors:  M Yamaguchi; N Mori
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

4.  Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead.

Authors:  A Cárdenas; H Roels; A M Bernard; R Barbon; J P Buchet; R R Lauwerys; J Roselló; I Ramis; A Mutti; I Franchini
Journal:  Br J Ind Med       Date:  1993-01

Review 5.  Prostaglandin inhibitors in the treatment of nephrotic syndrome.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

6.  Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice.

Authors:  Yuling Chi; Jean-Francois Jasmin; Yoshinori Seki; Michael P Lisanti; Maureen J Charron; David J Lefer; Victor L Schuster
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 7.  Physiopathological, Epidemiological, Clinical and Therapeutic Aspects of Exercise-Associated Hyponatremia.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  J Clin Med       Date:  2014-11-12       Impact factor: 4.241

8.  COX-2-derived PGE2 triggers hyperplastic renin expression and hyperreninemia in aldosterone synthase-deficient mice.

Authors:  Christian Karger; Katharina Machura; André Schneider; Christian Hugo; Vladimir T Todorov; Armin Kurtz
Journal:  Pflugers Arch       Date:  2018-02-17       Impact factor: 3.657

Review 9.  The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia.

Authors:  Sua Kim; Chor Ho Jo; Gheun-Ho Kim
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.